ERBB2 (Ab-877) Antibody

What is ERBB2 phosphorylation at Y877 and its functional significance?

ERBB2 (HER2) is a protein tyrosine kinase that functions as part of several cell surface receptor complexes. Phosphorylation at tyrosine 877 (Y877) represents a key regulatory site in the kinase domain that is homologous to Tyr416 of pp60c-Src . This phosphorylation site is involved in regulating ERBB2's biological activity, particularly its kinase function.

The phosphorylation at Y877 affects several downstream pathways. Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits phosphorylation and inhibition of GSK3B at the cell membrane, preventing phosphorylation of APC and CLASP2 and allowing their association with the cell membrane . This enables membrane-bound APC to facilitate the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization .

What applications are validated for ERBB2 (Ab-877) antibodies?

ERBB2 (Ab-877) antibodies have been validated for multiple research applications as summarized in the following table:

Each application requires specific optimization of antibody dilution and experimental conditions for optimal results .

What is the species cross-reactivity profile of commonly used ERBB2 (Ab-877) antibodies?

Based on manufacturer data, ERBB2 (Ab-877) antibodies show varying cross-reactivity profiles:

The cross-reactivity is based on 100% sequence homology in the region surrounding the Y877 site across these species .

How does Y877 phosphorylation relate to other phosphorylation sites on ERBB2/HER2?

ERBB2/HER2 contains multiple phosphorylation sites that regulate different aspects of its function:

• Y877: Located in the kinase domain, regulates kinase activity and biological function

• Y1221/1222: Major autophosphorylation sites that couple ERBB2 to the Ras-Raf-MAP kinase signal transduction pathway

• Y1248: Another major autophosphorylation site involved in MAP kinase pathway activation

• Y1112: Binding site for c-Cbl ubiquitin ligase, leading to ERBB2 poly-ubiquitination and enhanced degradation

These phosphorylation sites work in concert to regulate ERBB2's various functions, from kinase activity to protein stability and downstream signaling .

What role does Y877 phosphorylation play in ERBB2's nuclear functions?

ERBB2/HER2 has documented nuclear functions beyond its membrane receptor activities. In the nucleus, ERBB2 is involved in transcriptional regulation . It associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription . ERBB2 is also implicated in transcriptional activation of CDKN1A, a process that involves STAT3 and SRC .

Additionally, ERBB2 is involved in the transcription of rRNA genes by RNA Pol I, which enhances protein synthesis and cell growth . While the specific role of Y877 phosphorylation in these nuclear functions isn't fully elucidated in the available data, the phosphorylation state likely influences ERBB2's ability to interact with transcriptional machinery and DNA.

How can researchers validate the specificity of phospho-Y877 antibodies?

Validation of phospho-specific antibodies is crucial for reliable experimental results. To validate ERBB2 (Ab-877) antibodies, researchers should:

• Use positive and negative controls: Include cell lines with known ERBB2 phosphorylation status

• Perform phosphatase treatment: Treat samples with lambda phosphatase to confirm signal loss

• Conduct peptide competition assays: Pre-incubate the antibody with the immunizing phosphopeptide

• Compare with total ERBB2 detection: Run parallel samples with antibodies detecting total ERBB2

• Use specific kinase inhibitors: Treatment with ERBB2 kinase inhibitors should reduce phospho-Y877 signal

• Validate across multiple detection methods: Confirm findings using multiple techniques (e.g., WB, IP, IHC)

• Use siRNA/shRNA knockdown: Demonstrate specificity through reduced signal in ERBB2-depleted samples

What are the optimal sample preparation methods for detecting Y877 phosphorylation by Western blotting?

For optimal detection of phosphorylated ERBB2 at Y877 by Western blotting:

• Cell/Tissue Lysis:

  • Use RIPA or NP-40 based buffers with fresh phosphatase inhibitors

  • Include protease inhibitor cocktail to prevent protein degradation

  • Keep samples on ice during processing

• Protein Quantification and Loading:

  • Load 20-50 μg of total protein per lane

  • Use freshly prepared samples when possible

  • Molecular weight of ERBB2/HER2 is approximately 185 kDa

• Antibody Incubation:

  • Primary antibody dilution: 1:500-1:1000 (vendor-specific)

  • Incubate overnight at 4°C for optimal results

  • Use 5% BSA in TBST for blocking and antibody dilution (not milk, which contains phosphatases)

• Detection:

  • Use high-sensitivity ECL substrate for detection

  • Normalize phospho-Y877 signal to total ERBB2 expression

What controls should be included when using phospho-Y877 antibodies?

Proper experimental controls are essential when working with phospho-specific antibodies:

What are the recommended fixation and antigen retrieval protocols for IHC with ERBB2 (Ab-877) antibodies?

For immunohistochemical detection of phospho-Y877 ERBB2:

• Tissue Fixation:

  • Fix tissues in 10% neutral buffered formalin for 24-48 hours

  • Process and embed in paraffin following standard protocols

  • Section tissues at 4-5 μm thickness

• Deparaffinization and Rehydration:

  • Follow standard protocols for deparaffinization using xylene and graded alcohols

• Antigen Retrieval:

  • Heat-mediated antigen retrieval is typically recommended

  • Use citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

  • Retrieve using pressure cooker or microwave methods

• Blocking and Antibody Incubation:

  • Block endogenous peroxidase activity (3% H₂O₂ for 10 minutes)

  • Block non-specific binding (serum-based blocker)

  • Apply primary antibody at 1:50-1:200 dilution

  • Incubate overnight at 4°C or 1-2 hours at room temperature

• Detection and Visualization:

  • Use appropriate detection system (HRP-polymer or biotin-streptavidin)

  • Develop signal with DAB substrate

  • Counterstain with hematoxylin

How can researchers quantify changes in Y877 phosphorylation levels?

Quantitative assessment of Y877 phosphorylation is essential for many research applications:

• Western Blot Quantification:

  • Use densitometry software to measure band intensity

  • Normalize phospho-Y877 signal to total ERBB2 expression

  • Include standard curves if absolute quantification is needed

• IHC Quantification:

  • Implement digital image analysis for staining intensity measurement

  • Use H-score method (intensity × percentage of positive cells)

  • Consider automated systems for more objective assessment

• Flow Cytometry Quantification:

  • Measure mean fluorescence intensity (MFI) of phospho-antibody staining

  • Use appropriate isotype controls

  • Calculate fold-change relative to control conditions

• Advanced Quantification Methods:

  • Mass spectrometry for absolute quantification of phosphorylation stoichiometry

  • Multiplex assays to simultaneously measure multiple phosphorylation sites

  • Proximity ligation assays to detect protein interactions dependent on phosphorylation

How should researchers troubleshoot weak or absent signals when using ERBB2 (Ab-877) antibodies?

When troubleshooting phospho-Y877 detection:

• Sample Preparation Issues:

  • Ensure phosphatase inhibitors are fresh and effective

  • Process samples quickly to minimize dephosphorylation

  • Avoid repeated freeze-thaw cycles

• Antibody-Related Problems:

  • Verify antibody is stored properly (typically at -20°C)

  • Try a more concentrated antibody solution (reduce dilution)

  • Check antibody expiration date

• Protocol Optimization:

  • For Western blot: Try different blocking agents (BSA vs. milk)

  • For IHC: Optimize antigen retrieval conditions

  • Increase incubation time for primary antibody

  • Try different detection systems with higher sensitivity

• Technical Adjustments:

  • Increase protein loading amount

  • For Western blot: Check transfer efficiency and membrane type

  • For IHC: Adjust counterstaining procedure to improve contrast

How to interpret data when different anti-ERBB2 phospho-antibodies give conflicting results?

When faced with conflicting results using different phospho-antibodies:

• Validate antibody specificity using the methods described in Question 6

• Compare epitope sequences targeted by different antibodies

• Consider kinetics of phosphorylation at different sites (some may be more transient)

• Evaluate effects of sample preparation on different phosphorylation sites

• Use complementary techniques (e.g., mass spectrometry) to confirm phosphorylation status

• Review literature for known cross-talk between phosphorylation sites

• Consult antibody manufacturers for technical support and recommendations

What considerations are important when designing experiments to study Y877 phosphorylation dynamics?

When studying dynamic changes in Y877 phosphorylation:

• Temporal considerations:

  • Include appropriate time course (seconds to hours)

  • Synchronize cells when necessary

  • Consider rapid phosphorylation/dephosphorylation kinetics

• Stimulation conditions:

  • Use known activators of ERBB2 signaling (e.g., EGF family ligands)

  • Include positive controls (e.g., pervanadate to inhibit phosphatases)

  • Consider physiologically relevant concentrations

• Inhibitor studies:

  • Use specific ERBB2 kinase inhibitors as negative controls

  • Include broad-spectrum kinase inhibitors as appropriate

  • Consider inhibitor specificity and off-target effects

• Cellular context:

  • Evaluate phosphorylation in different cell types

  • Consider the influence of cell density and culture conditions

  • Examine effects of cell cycle phase

• Data analysis:

  • Perform statistical analysis appropriate for time-course data

  • Use curve-fitting to model phosphorylation/dephosphorylation kinetics

  • Compare relative phosphorylation levels across experimental conditions

How does Y877 phosphorylation contribute to ERBB2's role in cancer progression?

ERBB2/HER2 overexpression is detected in approximately 40% of human breast cancers . Phosphorylation at Y877, located in the kinase domain, may play several roles in cancer:

• Regulation of kinase activity:

  • Y877 phosphorylation may enhance ERBB2's catalytic activity

  • Increased kinase activity drives proliferative and anti-apoptotic signaling

• Impact on downstream signaling:

  • Affects activation of MEMO1-RHOA-DIAPH1 pathway

  • Influences cytoskeletal organization and cell migration

  • May contribute to metastatic potential

• Therapeutic implications:

  • Y877 phosphorylation status may influence response to ERBB2-targeted therapies

  • Could serve as a biomarker for treatment selection

  • May be involved in mechanisms of resistance to ERBB2 inhibitors

• Nuclear functions:

  • Phosphorylation may regulate ERBB2's role in transcriptional activation

  • Affects expression of genes involved in proliferation and survival

Understanding Y877 phosphorylation's contribution to cancer biology may inform the development of more effective targeted therapies and predictive biomarkers.